Theravance, Inc. (THRX) Reports Q3 Loss of 37c/Share

October 27, 2011 4:55 PM EDT
Theravance, Inc. (NASDAQ: THRX) reported Q3 EPS of ($0.37), $0.04 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $7.11 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings